Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Border

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Clinical Immunology and Immunopathology|May 1, 1983
Role of immunoglobulin class in mediation of experimental mesangial glomerulonephritisW A Border, A H Cohen
The New England Journal of Medicine|November 10, 1994
Transforming growth factor beta in tissue fibrosisW A Border, N A Noble
Seminars in Nephrology|December 1, 1989
Extracellular matrix and glomerular diseaseW A Border, S Okuda, T Nakamura
Diabetes/Metabolism Reviews|December 1, 1996
Transforming growth factor beta in diabetic nephropathyW A Border, T Yamamoto, N A Noble
Kidney International|April 12, 2000
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritisH Peters, W A Border, N A Noble
Current Opinion in Nephrology and Hypertension|July 1, 1994
Increased expression of transforming growth factor-beta in renal diseaseM Ketteler, N A Noble, W A Border
The American Journal of Physiology|August 1, 1994
Cytokines and L-arginine in renal injury and repairM Ketteler, W A Border, N A Noble
Current Opinion in Nephrology and Hypertension|July 1, 1997
Transforming growth factor-beta in human glomerular injuryH Peters, N A Noble, W A Border
Clinical and Experimental Immunology|May 1, 1980
Non-specificity of circulating immune complexes in patients with acute and chronic liver diseaseC K Abrass, W A Border, G Hepner
Annual Review of Physiology|January 1, 1995
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?M Ketteler, N A Noble, W A Border
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Clinical Immunology and Immunopathology|May 1, 1983
Role of immunoglobulin class in mediation of experimental mesangial glomerulonephritisW A Border, A H Cohen
The New England Journal of Medicine|November 10, 1994
Transforming growth factor beta in tissue fibrosisW A Border, N A Noble
Seminars in Nephrology|December 1, 1989
Extracellular matrix and glomerular diseaseW A Border, S Okuda, T Nakamura
Diabetes/Metabolism Reviews|December 1, 1996
Transforming growth factor beta in diabetic nephropathyW A Border, T Yamamoto, N A Noble
Kidney International|April 12, 2000
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritisH Peters, W A Border, N A Noble
Current Opinion in Nephrology and Hypertension|July 1, 1994
Increased expression of transforming growth factor-beta in renal diseaseM Ketteler, N A Noble, W A Border
The American Journal of Physiology|August 1, 1994
Cytokines and L-arginine in renal injury and repairM Ketteler, W A Border, N A Noble
Current Opinion in Nephrology and Hypertension|July 1, 1997
Transforming growth factor-beta in human glomerular injuryH Peters, N A Noble, W A Border
Clinical and Experimental Immunology|May 1, 1980
Non-specificity of circulating immune complexes in patients with acute and chronic liver diseaseC K Abrass, W A Border, G Hepner
Annual Review of Physiology|January 1, 1995
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?M Ketteler, N A Noble, W A Border
Pageof 11